Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

58.77
Delayed Data
As of Aug 26
 +0.01 / +0.02%
Today’s Change
56.32
Today|||52-Week Range
77.12
-14.57%
Year-to-Date
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
3 Beaten-Up Big Pharma Stocks: Are They Bargains?
Aug 14 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb Stock Will Bounce Back -- Here's How You Can Profit
Aug 22 / TheStreet.com - Paid Partner Content
Samsung biopharma unit lines up South Korea IPO
Aug 12 / FT.com - Paid Partner Content
These 3 Stocks Could Boost Their Dividends in the Next 12 Months
Aug 20 / MotleyFool.com - Paid Partner Content
Allergan setback prompts healthcare slide
Aug 08 / FT.com - Paid Partner Content
Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Aug 15 / Zacks.com - Paid Partner Content
AstraZeneca climbs to a record high
Aug 05 / FT.com - Paid Partner Content

Today’s Trading

Previous close58.76
Today’s open58.76
Day’s range58.54 - 59.40
Volume7,845,194
Average volume (3 months)8,463,263
Market cap$98.2B
Dividend yield2.59%
Data as of 4:01pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+29.67%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+4.29%
P/E ratio34.4
Price/Sales6.97
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.34+0.88%
AGNAllergan+1.62+0.69%
NVONovo Nordisk+0.04+0.09%
ABBVAbbVie-0.11-0.17%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs